Gilead Sciences: Innovative Biopharmaceutical Solutions for Life-Threatening Illnesses

We are committed to advancing health equity for patients throughout the cancer care journey. Through our Gilead Oncology Grant, we are providing $3.15 million to support 22 organizations in the U.S. that offer resources for individuals impacted by breast cancer.

Click here to know more.

Gilead Sciences, Inc. is a biopharmaceutical company focused on research, discovery, development, and commercialization of innovative treatments for unmet medical needs. The organization aims to transform and streamline care for individuals facing life-threatening diseases globally. Gilead operates in over 35 countries and is headquartered in Foster City, California.